Single tumor cell uptake and dosimetry of technetium-99m Fab' anti-CD22 in low-grade B-cell lymphoma

Cancer

Volumn 94, Issue 4 SUPPL., 2002, Pages 1270-1274

  Lindén, Ola ^a   Hindorf, Cecilia ^a   Tennvall, Jan ^a   Segrén, Sverker ^a   Wingardh, Karin ^a   Strand, Sven Erik ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dosimetry; Radioimmunotherapy; Single cell; Technetium 99m

Indexed keywords

MONOCLONAL ANTIBODY CD22 TC 99M; UNCLASSIFIED DRUG; CD19 ANTIGEN; CD22 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN G2A; TECHNETIUM 99M;

B CELL LYMPHOMA; CANCER REGRESSION; CASE REPORT; CELL POPULATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; DOSIMETRY; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION DOSE; RADIOACTIVITY; RADIOIMMUNOTHERAPY; ANTIGEN EXPRESSION; BLOOD SAMPLING; CANCER GRADING; FLOW CYTOMETER; LYMPHOMA CELL; MINIMAL RESIDUAL DISEASE;

EID: 0037083517     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10296     Document Type: Conference Paper

References (9)

1. Relationship between tumour size and curability for uniformly targeted therapy with beta emitting radionuclides
2. Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
3. Quantitation of CD38 expression using QuantiBRITE beads
4. 99mTc antibody conjugates
5. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis
6. Cytotoxicity with Auger electron-emitting radionuclides delivered by antibodies
7. Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin's lymphoma: Results of a pilot study